Dr. Nils Loewen is an Associate Professor of Ophthalmology, Department of Ophthalmology, University Pittsburgh Medical Center. Dr. Loewen also serves as the Director, Glaucoma and Cataract Services, the Director, Glaucoma Fellowship Program, and the Director, Electronic Health Records, all of the University Pittsburgh Medical Center.
Dr. Loewen studied electrophysiology and medicine at Albert-Ludwigs-University, Freiburg, Federal Republic of Germany. He received his PhD in molecular medicine from Mayo Graduate School, Rochester, Minnesota, and The Open University, Milton Keynes, United Kingdom. Dr. Loewen trained with Dr. Robert Weinreb at the Hamilton Glaucoma Center at the University of California, San Diego.
Clinically, Dr. Loewen is specialized in Glaucoma and Cataract care. He provides new, minimally invasive glaucoma procedures that are bleb-free and have very comprehensive experience with trabectome surgery. Dr. Loewen also offers small incision trabeculectomy and canaloplasty. In addition to regular cataract surgery, he performs complex cataract procedures and anterior segment reconstruction.
In Dr. Loewen’s basic research, his lab is focused on bioengineering of the ocular outflow system to lower eye pressure (NIH K08EY022737 “Reverse Engineering of Trabecular Meshwork”). He spearheaded gene therapy for glaucoma with lentiviral vectors and developed a technique to permanently genetically modify the outflow tract of the eye, the site of the primary pathology in glaucoma. The lab’s current research is focused on using these tools to reverse engineer a working outflow tract with stem cells as a novel treatment of glaucoma.
Dr. Loewen has authored more than 90 abstracts, articles, book chapters, and patents and is a reviewer for 14 scientific journals. He is a member of the American Glaucoma Society, American Academy of Ophthalmology, and Association for Research in Vision and Ophthalmology.
View a list of Dr. Loewen’s publications here.